Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

Upstream Bio, Inc. (UPB) has received a new Buy rating, initiated by TD Cowen analyst, Yaron Werber. Yaron Werber has given his Buy rating due ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

This page features the latest news about the Upstream Bio stock. OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares OrbiMed Advisors LLC, a prominent shareholder in Upstream Bio ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

In this interview, Simon Wieninger discusses the critical role digital tools play in improving bioprocessing efficiency, how ...

Now may be the time for investors grab some of the highest-yielding energy stocks, and these three offer some hefty and ...

Upstream Bio Stock (NASDAQ: UPB) stock price, news, charts, stock research, profile.

Q3 2024 Earnings Conference Call November 1, 2024 11:00 AM ETCompany ParticipantsPeter Shaw - VP, IRBrad Corson - ...

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and Fina Biosolutions LLC (FinaBio), experts in ...